A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors. [electronic resource]
Producer: 20030124Description: 148-54 p. digitalISSN:- 0008-543X
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Capecitabine
- Cohort Studies
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Fluorouracil -- analogs & derivatives
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Staging
- Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.